ArticleScientific reports2022

Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa.

Robbie R Haines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.